Using the same mouse model, HIF2α was demonstrated to also trigger the activation of the iron reductase six-transmembrane epithelial antigen of the prostate 4 (STEAP4), causing mitochondrial iron accumulation, elevated ROS levels, and increased tumor burden [126]. Here, STEAP4 is linked to neoplasm.